Canntab Therapeutics Ltd (CTABF)
0.0001
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
Canntab Therapeutics Net Income (Quarterly): -0.3058M for Feb. 28, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| February 28, 2023 | -0.3058M |
| November 30, 2022 | -0.7643M |
| August 31, 2022 | -0.3625M |
| May 31, 2022 | -1.135M |
| February 28, 2022 | -0.3289M |
| November 30, 2021 | -0.9734M |
| August 31, 2021 | -0.4849M |
| May 31, 2021 | -1.858M |
| February 28, 2021 | -0.474M |
| November 30, 2020 | -0.4629M |
| August 31, 2020 | -0.6702M |
| May 31, 2020 | -0.6241M |
| February 29, 2020 | -0.5093M |
| November 30, 2019 | -0.4712M |
| August 31, 2019 | -0.3327M |
| May 31, 2019 | -0.4091M |
| February 28, 2019 | -0.5073M |
| November 30, 2018 | -0.6019M |
| August 31, 2018 | -0.3409M |
| May 31, 2018 | -1.293M |
| March 31, 2018 | -0.0423M |
| February 28, 2018 | -0.2291M |
| December 31, 2017 | -0.0272M |
| September 30, 2017 | -0.0336M |
| June 30, 2017 | -0.0514M |
| Date | Value |
|---|---|
| March 31, 2017 | -0.0276M |
| December 31, 2016 | -0.1054M |
| September 30, 2016 | -0.0743M |
| June 30, 2016 | -0.0933M |
| March 31, 2016 | 0.6394M |
| December 31, 2015 | -0.0363M |
| September 30, 2015 | -0.0299M |
| June 30, 2015 | -0.0379M |
| March 31, 2015 | -0.0319M |
| December 31, 2014 | -0.0409M |
| September 30, 2014 | -0.0376M |
| June 30, 2014 | -0.0472M |
| March 31, 2014 | -0.036M |
| December 31, 2013 | 0.2374M |
| September 30, 2013 | -0.0772M |
| June 30, 2013 | -0.1157M |
| March 31, 2013 | -0.3493M |
| December 31, 2012 | -0.3201M |
| September 30, 2012 | -0.3037M |
| June 30, 2012 | -0.4462M |
| March 31, 2012 | -0.486M |
| December 31, 2011 | -0.2553M |
| September 30, 2011 | -1.065M |
| June 30, 2011 | -0.0521M |
| March 31, 2011 | -0.0988M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-1.858M
Minimum
May 2021
-0.3058M
Maximum
Feb 2023
-0.6732M
Average
-0.4971M
Median
Net Income (Quarterly) Benchmarks
| Biosyntech Inc | -- |
| Cotinga Pharmaceuticals Inc | -0.4055M |
| Choom Holdings Inc | -4.68M |
| Acasti Pharma Inc | -2.617M |
| Aurinia Pharmaceuticals Inc | 0.722M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | -0.0164M |
| Total Expenses (Quarterly) | 0.3724M |
| EPS Diluted (Quarterly) | -0.0074 |